Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
Introduction: Majority of euroendocrine tumorsare found in the gastrointestinal tract and bronchopulmonary. Multifocal disease is common among patients with low-grade NET. One example of this is diffuse idiopathic pulmonary neuroendocrine cell hyperplasia. DIPNECH is an extremely rare but indolent disease with predilection for nonsmoking, middle-aged women.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author: Cruz M
Authors: Cruz M,
Keywords: DIPNECH, Neuroendocrine tumor, carcinoid,
Introduction: Patients with grade 3 neuroendocrine neoplasm (NEN G3) have a limited prognosis. Even in a non-metastatic stage, the risk of recurrence after surgery is high. Multimodal perioperative treatment, including chemotherapy and/or radiotherapy in an adjuvant or neoadjuvant setting, has improved the prognosis in numerous tumor entities; however, it has not been systematically evaluated in NEN G3 so far. Nevertheless, perioperative chemotherapy is generally recommended in most current treatment guidelines for NEN G3.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author:
Authors: Apostolidis L, Starke H, Bhatti I, Jäger D, Winkler E,
Keywords: NEN G3, neuroendocrine carcinoma, adjuvant, neoadjuvant, surgery,
Introduction: Gastroenteropancreatic neuroendocrine tumours (GEP NET) can adversely affect nutritional status. Cross-sectional studies report up to 25% of GEP NET patients are malnourished and dietary change may be prevalent. Nevertheless, clinical guidelines lack advice on nutrition management.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author: Laing E
Authors: Laing E, Kiss N, Michael M, Krishnasamy M, Gough K,
Keywords: neuroendocrine, nutrition, malnutrition, weight change, symptoms,
Introduction: Adrenocortical carcinoma (ACC) in adults is a rare tumor (incidence 0.7-2/1000000/year). Median overall survival is 3-4 years and five-year survival is 0-28% in metastatic disease. The only curative therapy is complete surgical resection, plus adjuvant therapy depending on poor prognostic factors (ENSAT stage III, R1 resection or Ki67>10%). Both recurrent oligometastatic disease and patients who respond to systemic treatment (ST), a radical approach with surgery or local therapy (LT) may be treatment options.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author:
Authors: Morales Herrero R, Herrero Rivera D, Santos Fernández P, Benavent M,
Keywords: ACC, chemotherapy, mitotane, local therapy,
Introduction: Classification of appendiceal neuroendocrine neoplasms (aNEN) changed significantly over the years and treatment algorithm remains a matter of debate.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author: Ribeiro S
Authors: Ribeiro S, De Maeyer F, De Man M, Carton S, Cuyle P,
Keywords: appendiceal NET, incidence in community, subtypes/WHO grade, management decisions,